John Hamill
Net worth: 24 115 $ as of 2026-06-29
Net worth: 24 115 $ as of 2026-06-29
John P.
Hamill is Chairman at CVie Therapeutics Ltd., Member of The American Institute of Certified Public Accountants, Member of the Pennsylvania Institute of Certified Public Accountants, and Secretary, Chief Financial & Accounting Officer at Aprea Therapeutics, Inc. Former roles include Chief Financial Officer & Senior Vice President at Windtree Therapeutics, Inc. (2020–2023), Vice President-Finance at Trevena, Inc. (2018–2019), Interim Chief Financial Officer at Cellectar Biosciences, Inc. (2017–2018), CEO, CFO, Secretary & Treasurer at Medpace Research, Inc. (2016–2017), Co-President & Chief Financial Officer at Savient Pharmaceuticals, Inc. (2012–2014), Chief Financial Officer & Executive Vice President at inVentiv Health Clinical, Inc., and Principal at Johnson & Johnson and Rhone-Poulenc Pharmaceuticals North America.
Education includes an undergraduate degree from DeSales University, conferred in 1986.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-20 | 30,069 ( 0.24% ) | 24 115 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| APREA THERAPEUTICS, INC. | Director of Finance/CFO | 2023-01-29 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Corporate Officer/Principal | - |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Chairman | - |
| Companies | Position | End |
|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Director of Finance/CFO | 2023-01-26 |
| TREVENA, INC. | Comptroller/Controller/Auditor | 2018-07-31 |
| CELLECTAR BIOSCIENCES, INC. | Director of Finance/CFO | 2018-03-31 |
| NEPHROGENEX INC | Chief Executive Officer | 2017-04-30 |
| SAVIENT PHARMACEUTICALS INC | Director of Finance/CFO | 2013-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products | Health Technology |
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
DeSales University
DeSales University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Research, Inc.
Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Pennsylvania Institute of Certified Public Accountants
Pennsylvania Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates as a statewide professional association for certified public accountants | Commercial Services |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Rhone-Poulenc Pharmaceuticals North America | |
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
CVie Therapeutics Ltd.
CVie Therapeutics Ltd. BiotechnologyHealth Technology Develops and researched drugs | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Select your edition
All financial news and data tailored to specific country editions